
Sign up to save your podcasts
Or


We discuss the use of a novel oral agent for the treatment of diabetic retinopathy with David R. Lally, MD, Director of Research, New England Retina Consultants, Springfield, MA
By Retina Synthesis4.5
88 ratings
We discuss the use of a novel oral agent for the treatment of diabetic retinopathy with David R. Lally, MD, Director of Research, New England Retina Consultants, Springfield, MA

43 Listeners

18 Listeners

97 Listeners

5 Listeners

6,068 Listeners

4 Listeners

21 Listeners

10 Listeners

50 Listeners

11 Listeners

19 Listeners

0 Listeners

1 Listeners

18 Listeners

0 Listeners